Sanjay Srivastava, Ph.D.

Principal Scientist, Computational Chemistry

Dr. Sanjay Srivastava has over 20 years of experience in generating and applying Computational Chemistry and Cheminformatics-led solutions to problems in Drug Discovery. He has led or participated in the introduction of several novel computational paradigms for improving drug design strategies. Prior to joining Circle, he set up and led a new CADD section in a Canadian CRO (Paraza Pharma), where he supported several structurally enabled projects for industry and academic clients. Sanjay has also served as a Computational Chemistry and Cheminformatics consultant to the biotech start-up sector. In previous roles in large pharma, he helped to establish and manage a Cheminformatics platform which impacted multiple Antiviral projects (Boehringer-Ingelheim) and was part of the C-Lab global team that was successful in implementing & utilizing machine learning derived in-silico ADME models to drive preclinical research decisions (AstraZeneca). In addition to Antivirals, Sanjay has also supported multiple other therapeutic areas, including AstraZeneca’s several CNS/Pain projects that advanced candidate compounds to the clinical phase. Prior to his industry forays, Sanjay completed postdoctoral fellowships at University of Michigan, Ann Arbor and National Research Council, Montreal (Canada). Dr. Srivastava obtained his Ph.D. in Computational Chemistry from Case Western Reserve University. He also holds a Master’s and an undergraduate degrees from IIT, Kanpur (India) and St. Stephen’s College, Delhi (India), respectively.

Go to Top